Le Lézard
Classified in: Health, Business
Subjects: ERN, ACC

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2024


Zinzino group revenue increased with a total of 35 %, compared with the previous year.

GOTHENBURG, Sweden, May 6, 2024 /PRNewswire/ -- The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK 163.7 (121.2) million compared with the previous year.

Accumulated revenue for January ? April 2024 increased by 20 % to SEK 618.2 (514.9) million.

Revenues were distributed as follows:


Regions,MSEK

24-Apr

23-Apr

Change

YTD 2024

YTD 2023

Change

The Nordics

24.7

21.5

15 %

92.8

95,0

-2 %

Central Europe

44.9

29.3

53 %

164.4

120.2

37 %

East Europe

31.1

30.6

2 %

124.9

123.1

1 %

South & West Europe

25.5

15.6

63 %

96.1

64.7

49 %

The Baltics

8.1

7,0

16 %

32,0

28.1

14 %

North America

15.0

5.8

159 %

50.4

25.4

98 %

Asia-Pacific

5.3

5.2

2 %

17.6

20.8

-15 %

Africa

1.1

1,0

10 %

4.4

4.8

-8 %

Zinzino

155.7

116.0

34 %

582.6

482.1

21 %

Faun Pharma

8,0

5.2

54 %

35.6

32.8

9 %

Zinzino Group

163.7

121.2

35 %

618.2

514.9

20 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge: [email protected]

Certified Adviser: Carnegie Investment Bank AB (publ)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-april-2024,c3973683

The following files are available for download:

https://mb.cision.com/Public/10976/3973683/82ccc33138be2a5e.pdf

2404 Press release Salesreport EN

 


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: